Christopher Astle

Insider Reports History

Entity
Individual
Location
114 East 4 Th Avenue, Suite 800, Vancouver, British Columbia, Canada
Signature
/s/ Daniel Dex, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Astle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zymeworks Inc. SVP & Chief Financial Officer Restricted Stock Unit 30K $336K $11.22 Jan 5, 2024 Direct
Zymeworks Inc. SVP & Chief Financial Officer Common Stock 6.5K $72.9K $11.22 Jan 8, 2024 Direct
Zymeworks Inc. SVP & Chief Financial Officer Stock Option (Right to Buy) 125K Mar 10, 2022 Direct
Zymeworks Inc. SVP & Chief Financial Officer Stock Option (Right to Buy) 50K Jan 5, 2024 Direct

Insider Reports Filed by Christopher Astle

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZYME Zymeworks Inc. Jan 5, 2024 6 -$64.7K 4 Jan 8, 2024 SVP & Chief Financial Officer
ZYME Zymeworks Inc. Dec 11, 2023 3 -$8.09K 4 Dec 11, 2023 SVP & Chief Financial Officer
ZYME Zymeworks Inc. Jan 5, 2023 2 $0 4 Jan 6, 2023 SVP & Chief Financial Officer
ZYME Zymeworks Inc. Dec 12, 2022 3 -$5.33K 4/A Dec 23, 2022 SVP & Chief Financial Officer
ZYME Zymeworks Inc. Mar 10, 2022 1 $0 4 Mar 11, 2022 SVP & Chief Financial Officer
ZYME Zymeworks Inc. Feb 24, 2022 0 $0 3 Mar 4, 2022 SVP & Chief Financial Officer